Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia

The natural history of untreated subretinal neovascular membranes (SRNVM) associated with idiopathic macular telangiectasia (IMT) is generally poor with 81% of eyes in a series of 26 eyes having a (cid:222) nal visual acuity of 20/200 or worse. [1] Photocoagulation and sub-retinal surgery for treatment of SRNVM associated with IMT have not shown good results. [2,3] Photodynamic therapy (PDT) and intravitreal bevacizumab have been used individually for treatment of such eyes; [4,5] Combination PDT and ranibizumab has also been reported. [6] However, there are no reports on combination PDT and intravitreal bevacizumab for such eyes. A gentleman 20/60 le ft Fundus 2A IMT right ndings con

• Publication year

  2009

• Venue

  Indian Journal of Ophthalmology

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0301-4738.49406PMID 19384026PMCID 2683442
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combined photodynamic therapy and intravitreal ranibizumab as primary treatment for subretinal neovascular membrane (SRNVM) associated with type 2 idiopathic macular telangiectasia

  2008cited by this paper
• Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia

  2007cited by this paper
• Idiopathic Macular Telangiectasia

  2006cited by this paper
• Photodynamic therapy for subretinal neovascularization in type 2A idiopathic juxtafoveolar telangiectasis.

  2006cited by this paper
• Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis.

  2002cited by this paper
• Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

  1997cited by this paper
• Bilateral subretinal neovascular membrane in idiopathic juxtafoveolar telangiectasis.

  1996cited by this paper

• Expected role of photodynamic therapy to relieve skin damage in nuclear or radiological emergency: Review.

  2024cites this paper
• Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature

  2017cites this paper
• LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2

  2016cites this paper
• Changing paradigms of anti-VEGF in the Indian scenario

  2014influential citation
• Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, Mac Tel 2).

  2013influential citation
• Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia

  2012cites this paper
• Primitive Retinal Vascular Abnormalities: Tumors and Telangiectasias

  2012cites this paper
• Idiopathic Juxtafoveolar Retinal Telangiectasis

  2010cites this paper
• Intravitreal bevacizumab for type 1 idiopathic macular telangiectasia

  2010cites this paper
• VISIBLE AND EXUDATIVE IDIOPATHIC JUXTAFOVEOLAR RETINAL TELANGIECTASIS ( “ Idiopathic Macular Telangiectasia Type 1 ” or “ Aneurysmal Telangiectasia ” )

  2010cites this paper
• The Ostrich Should be the National bird of India

  2010cites this paper
• Idiopathic Juxtafoveolar Retinal Telangiectasis: A Current Review

  2010cites this paper